Investigational drug · Phase 3
T89
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Chronic Stable Angina Pectoris.
Phase 3Last checked: Nov 19, 2026Latest source record: Apr 9, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
18
Any phase or sponsor naming "T89"
First trial start
2019
Aug 1, 2019
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "T89", any sponsor or status.
Conditions studied
As listed on its trial records.
- Chronic Stable Angina Pectoris
Largest trials
Live from ClinicalTrials.gov: studies naming "T89" as an intervention, largest first.
- Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable AnginaPivotal-lookingCompleted
Tasly Pharmaceuticals, Inc.Industry
NCT01659580 · 1,004 participants · Start Aug 2012 · Primary completion Dec 2016
Drug: T89 high dose; T89 Low dose and 2 more · For: Angina Pectoris
Sites: Little Rock, Arkansas; Banning, California; La Jolla, California · 94 sites in all
- Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)Pivotal-lookingCompleted
Tasly Pharmaceuticals, Inc.Industry
NCT04993729 · 853 participants · Start Jul 21, 2021 · Primary completion May 26, 2023
Drug: T89 capsule; Placebo capsule · For: Acute Mountain Sickness (AMS)
Sites: San Francisco, California; Chengdu, China; Lhasa, China
- Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable AnginaPivotal-lookingRecruiting
Tasly Pharmaceuticals, Inc.Industry
NCT03789552 · 765 participants (planned) · Start Aug 1, 2019 · Primary completion Dec 2026
Drug: T89 capsule; Placebo capsule · For: Chronic Stable Angina Pectoris
Sites: Naples, Florida
- Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping PillsPivotal-lookingRecruiting
Qilu Hospital of Shandong UniversityAcademic, hospital or other
NCT07885462 · 496 participants (planned) · Start Nov 2026 · Primary completion Nov 2028
Drug: Compound Danshen Dripping Pills; Placebo · For: Coronary Microvascular Disease
Sites: Jinan, China
- Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic RetinopathyPivotal-lookingStatus unknown
Tasly Pharmaceuticals, Inc.Industry
NCT02388984 · 480 participants (planned) · Start May 2013 · Primary completion May 2017
Drug: Compound danshen dripping pills; Placebo · For: Non-proliferative Diabetic Retinopathy
Sites: Beijing, China; Chongqing, China; Guangzhou, China · 16 sites in all
- Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal ComplicationsPivotal-lookingStatus unknown
Nanfang Hospital, Southern Medical UniversityAcademic, hospital or other
NCT03216759 · 182 participants (planned) · Start Aug 2017 · Primary completion Oct 2018
Drug: Dexmedetomidine · For: Intestinal Complications; Laparotomy
- Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)Pivotal-lookingCompleted
Tasly Pharmaceuticals, Inc.Industry
NCT03552263 · 132 participants · Start Jun 7, 2018 · Primary completion Oct 20, 2019
Drug: T89 capsule; Placebo capsule · For: Acute Mountain Sickness (AMS)
Sites: San Francisco, California
- Phase II Multi-Center Study of T89 to Treat Chronic Stable AnginaPivotal-lookingCompleted
Tasly Pharmaceuticals, Inc.Industry
NCT00797953 · 124 participants · Start Feb 2007 · Primary completion Dec 2009
Drug: T89 · For: Angina Pectoris
Sites: Tucson, Arizona; Beverly Hills, California; Corona, California · 15 sites in all
- Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy PainPivotal-lookingStatus unknown
Affiliated Hospital of Nantong UniversityAcademic, hospital or other
NCT05175001 · 100 participants (planned) · Start May 1, 2021 · Primary completion Jun 30, 2022
Drug: Diprospan; Ropivacaine · For: Chronic Pain
Sites: Nantong, China
Zhejiang Cancer HospitalAcademic, hospital or other
NCT06173466 · 96 participants · Start Dec 15, 2023 · Primary completion Feb 28, 2024
Drug: Liposomal bupivacaine; Bupivacaine Hydrochloride combined with dexamethasone · For: Liver Cancer
Sites: Hangzhou, China
Newest research
PubMed records naming it or its code names, newest first.
- [Underestimated Risk in Ankylosing Spondylitis: Iatrogenic Thoracic Spine Fracture During Revision Hip Arthroplasty With Fatal Outcome].
Yacoub S, Heyde CE, Pieroh P, et al. · Z Orthop Unfall 2026
- Intracranial, Intra-, and Epidural Pressure Changes During Endoscopic Lumbar Discectomy: A Comparison Between Transforaminal and Interlaminar Approach.
Stauffer A, Schader JF, Zipser CM, et al. · Spine (Phila Pa 1976) 2026
- Posterior circumferential decompression for multilevel thoracic ossification of the posterior longitudinal ligament: a case report and literature review.
Ren L, Liu H, Sun C, et al. · Front Surg 2026
- Slow-growing hematoma in the thoracic ligamentum flavum: illustrative case.
Fujihara F, Uchikado H, Irie Y, et al. · J Neurosurg Case Lessons 2026
- Solution-shearing strategy for improved anchoring of self-assembled monolayers in inverted perovskite solar cells.
Xu W, Zhang L, Tang J, et al. · Chem Commun (Camb) 2026
- Proximal junctional failure combined with symptomatic thoracic disc herniation: a rare case report.
Zhang X, Klein L, Mühlenfeld N, et al. · Spine Deform 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.